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Regular exercise plays a key role in the maintenance of health and physical capabilities. 
Extensive research shows that exercise is an efficient method to prevent diabetes. Both 
resistance and aerobic exercise training are well known countermeasures for insulin resistance. 
However, depending on factors like purpose, capability and accessibility, different exercise 
modes need to be evaluated on both applied and molecular levels. In addition, exercise is the 
means to improve performance. New training strategies have emerged, like training with low 
glycogen stores or combining strength with endurance training, and guidelines based on 
empirical data are needed. Although knowledge of exercise physiology has advanced, much 
more needs to be learned before we can exploit the full potential of exercise with regard to 
health and performance. Therefore, the overall aim of this thesis is to provide knowledge of 
how different exercise strategies improve performance and insulin sensitivity. The 
mitochondria represent a central part of this thesis considering their key role in both health and 
performance. Study I was an acute crossover investigation of the effect of exercise with low 
glycogen levels on markers of mitochondrial biogenesis. Study II investigated the effect of 
concurrent resistance and endurance training on mitochondrial density and endurance 
performance. Study III investigated the acute effect of exercise on starvation-induced insulin 
resistance. In Study IV, the effect of resistance exercise training on health and performance in 
the elderly was investigated. The main findings were: 
 Training with low glycogen levels enhanced the response in markers of mitochondrial 
biogenesis. 
 Adding resistance training to endurance training did not improve mitochondrial density 
or endurance performance in trained individuals. 
 Resistance training for only eight weeks is an efficient strategy to improve strength, 
heart rate (HR) during submaximal cycling and glucose tolerance in elderly. It also 
improves muscular quality by increasing mitochondrial and hypertrophy signaling 
proteins. 
 Starvation-induced insulin resistance is attenuated by exercise. Mitochondrial 
respiration and reactive oxygen species (ROS) production is reduced during starvation. 
Exercise during starvation reduced glycogen stores and resulted in the activation of 
enzymes involved in glucose metabolism. 
 When exercise was performed during starvation there was an increase in markers for 
mitochondrial lipid oxidation. 
In conclusion, training with low glycogen stores seems to be a promising strategy to increase 
mitochondrial density. In contrast to our previous acute findings, concurrent training had no 
effect on mitochondrial biogenesis or endurance performance. Exercise can reverse yet another 
mode of insulin resistance (starvation) which strengthens its role in the treatment for other 
states of insulin resistance, e.g. Type 2 diabetes (T2D). Resistance exercise training is an 
efficient and safe strategy for the elderly to improve health and performance. 
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1 INTRODUCTION 
Physical inactivity has been identified as one of the greatest public health problems in our 
time. Physical activity is defined as bodily movement produced by skeletal muscle that 
requires energy expenditure. Increasing physical activity brings many health benefits 
regarding cardiovascular disease, diabetes, cancer, hypertension, obesity, depression and 
osteoporosis (147). For these reasons, the American College of Sports Medicine (ACSM) has 
minimum recommendations regarding physical activity. Adults should perform at least 150 
minutes per week of moderate intensity or 75 minutes per week of vigorous intensity cardio 
respiratory exercise training. On two to three days per week resistance exercise should also be 
performed (55). Meeting these recommendations with either resistance or aerobic exercise 
training is associated with a lower risk of diabetes of 34% or 52%, respectively (60). 
Unfortunately, most individuals fail to meet these recommendations. At least partly because 
of that, insulin resistance and T2D are widespread diseases and major problems, both on 
individual and socioeconomic levels. Between 1980 and 2008, Type 2 diabetics increased 
across the world from 153 to 347 million (43). By the year 2050 diabetes prevalence is 
estimated to be as high as 33% in the U.S. population (25). An especially vulnerable group is 
the elderly. About one-third of the U.S. population over 60 years has diabetes, which is 
almost twice the proportion compared to middle-aged adults. Of these, approximately half are 
undiagnosed and an additional third have pre-diabetes (40). 
However, exercise is not merely a tool for disease prevention; it is also the way to increase 
performance. It is well known that improved performance, up to a certain level, and health go 
hand-in-hand. For example, well trained individuals tend to be highly insulin sensitive (118) 
and there is a negative association between exercise capacity and mortality (83). 
In a traditional view, depending on factors like intensity, duration, initial training status and 
genetic disposition, endurance exercise training results in improved aerobic capacity (68), 
while strength training results in increased strength and hypertrophy (136). However, the 
effects of the different exercise modes seem to be more intertwined and dependent upon 
initial training status. Effects previously considered specific for one mode, may in fact 
emerge from another. As an example, during some conditions, strength training can improve 
cycling economy (119). Similarities in the outcome between different exercise modes are not 
exclusive for performance; insulin sensitivity also benefits from both endurance and strength 
training (60). The health benefits of strength training have not been acknowledged for long; 
not until 1990 did ACSM add strength training to their recommendations on physical activity. 
1.1 MITOCHONDRIA 
Oxidative phosphorylation is a process that occurs in the mitochondria in which nutrients are 
metabolized while oxygen is consumed. The purpose of oxidative phosphorylation is to 
transform energy from nutrients into adenosine triphophate (ATP), the energy currency of the 
cell. The process is carried out through the metabolic pathways such as the citric acid cycle, 
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beta oxidation and the electron transport chain (ETC) (Figure 1). The ETC consists of five 
complexes across the inner membrane of the mitochondria. In a series of reduction and 
oxidation reactions, electrons are transported across the complexes. These reactions release 
energy that enables the transport of protons from the matrix to the inter-membrane space, 
which builds up a proton gradient across the membrane. The gradient then drives ATP 
synthase to resynthesize ATP from adenosine diphosphate (ADP). The redistribution of 
electrically charged protons creates an electrochemical gradient across the inner membrane. 
The very central role of mitochondria in cell metabolism makes mitochondria a key player in 
several body functions and health issues. Mitochondrial density and function have been 
associated with cardiovascular disease (104), sarcopenia (106), insulin resistance and T2D 
(135), aging (109) and aerobic capacity (75, 148). 
 
 
Figure 1. The electron transport chain across the mitochondrial inner membrane. CI-IV, 
complex I-IV; H, hydrogen; ROS, reactive oxygen species.  
 
1.1.1 Reactive oxygen species (ROS) 
Mitochondria are not merely energy transducers; they also produce ROS as a byproduct of 
oxidative phosphorylation. ROS are highly reactive compounds that can oxidize and react 
with different cell compartments. Endogenous and exogenous antioxidants neutralize ROS 
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and together they coexist in a balance referred to as the redox environment. The redox 
environment is affected by any changes in the presence of either ROS or antioxidants, e.g. 
through antioxidant supplementation or exercise. Since ROS are highly reactive molecules 
with the potential to damage cell structures, they have for several decades been viewed solely 
as something negative. More recently, research has identified ROS as a regulator of cell 
signaling, which suggests a more complex role (111). 
Mitochondria are a major source of ROS (9). In diabetes, they seem to be responsible for the 
majority of excess chronic ROS production (102, 103). In the mitochondria, the main sites of 
ROS production are the ETC complexes I and III (13). Mitochondrial ROS formation is 
closely related to the electrochemical gradient across the inner membrane. ROS formation is 
low until the gradient rises and then it becomes sensitive to small changes (85). High 
substrate availability increases the electron pressure in the ETC, which increases the 
electrochemical proton gradient. This makes ROS production sensitive to the substrate 
availability of the cell. For unknown reasons, mitochondria from Type IIB fibers seem to 
produce more ROS than those from Type I fibers (8). Muscle contraction, and thus exercise, 
are well known initiators of ROS production. However, observations from experiments in our 
lab (unpublished) and others (45, 81) show that mitochondria produce more ROS in state 4 
(basal) respiration compared to active state 3 (maximal ADP stimulated) respiration. In 
addition, mitochondrial ROS production during contraction seems to be much lower than 
previously estimated (111). This shows that the major part of exercise induced ROS 
production probably emerges from sources other than the mitochondria, e.g. nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase and xanthine oxidase (111). 
For several decades ROS production during exercise was seen as a negative byproduct that 
interfered with performance and recovery. This led to numerous studies investigating the 
beneficial effects of antioxidant supplementation in combination with exercise. Generally, the 
studies found reduced markers of oxidative stress. However, this did not coincide with any 
improvements in performance or recovery (63). More recently, several studies have shed new 
light on the role of ROS. Suppression of ROS by antioxidant supplementation seems to blunt 
the response to exercise training. Oral administration of antioxidants (vitamins C and E) 
hampered training effects on maximal running time in rats (58). In humans VO2max, insulin 
sensitivity, transcription of peroxisome-proliferator-activated receptor γ coactivator 1- α 
(PGC-1α), peroxisome-proliferator-activated receptor γ (PPARγ) and endogenous 
antioxidants were hampered (58, 116). Thus, ROS seems to be an important factor for cell 
signaling and mediating exercise adaptation (111). 
The ability to interfere with signaling pathways makes ROS a potential candidate for the 
development of insulin resistance. Increased ROS formation causes inhibiting 
phosphorylations of the insulin receptor substrate 1 (IRS-1), an intermediate of the insulin 
signaling pathway (103). The ability of ROS to induce insulin resistance in some conditions 
and yet be an essential part of exercise induced insulin sensitivity (116) is clearly a paradox. 
An explanation for this might be the duration of ROS exposure. Chronic elevated levels seem 
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to be harmful while short intense exposure, e.g. following exercise, seems to activate cell 
signals. Another possible explanation is the source of ROS production, e.g. mitochondria, 
NADPH oxidase or xanthine oxidase (111). As mentioned previously, mitochondria seem to 
be responsible for the elevated ROS levels in diabetics, while during contractions, other 
sources seem to dominate (111). 
1.1.2 Aerobic capacity 
Aerobic capacity is measured as the maximal oxygen uptake, VO2max. The major 
physiological limitation for VO2max is O2 delivery to the muscle. The main cause for 
changes in VO2max following training or long-term immobilization is changes in stroke 
volume (15). Although mitochondrial volume correlates strongly with VO2max (70, 148), 
changes in mitochondria only correspond with minor changes in VO2max (15). Even so, 
mitochondrial volume correlates with performance (75) and responds well to training (137). 
Increased mitochondrial density affects performance independent of VO2max by maintaining 
cellular homeostasis at higher work rates relative to VO2max, which will improve lactate 
threshold. Increased mitochondrial density also improves the ability to oxidize fat to preserve 
glycogen stores (69). It is therefore of great interest for the athlete to find new strategies to 
increase mitochondrial biogenesis and thereby performance. 
1.1.3 PGC-1α 
PGC-1α is a major regulator of mitochondrial biogenesis and plays an important role in cell 
metabolism. When activated, PGC-1α binds to and co-activates several nuclear transcription 
factors, including PPARγ, nuclear respiratory factors (NRF-1 and -2) and the mitochondrial 
transcription factor A (Tfam) (57). By doing so, the transcription of several different genes 
are induced and proteins are translated, including PGC-1α  itself (20). 
Exercise is a potent up-regulator of PGC-1α (20). The activation of PGC-1α following 
exercise is initiated by several mechanisms. Ca
2+
 release during muscle contraction 
phosphorylates calcium/calmodulin-dependent protein kinase type IV (CaMKIV) activates 
cAMP response element-binding protein (CREB), a potent activator of PGC-1α (155). 
Intracellular energy stress is another activator. An increase in the adenosine monophosphate 
(AMP)/ATP ratio activates AMP-activated protein kinase (AMPK) which triggers several 
pathways directed to increase ATP level. One of these pathways includes PGC-1α (76). PGC-
1α activation seems also to be sensitive to the redox environment. Exposure of cultured 
myotubes with ROS caused an induction of PGC-1α. The addition of the antioxidant N-
acetylcystein then inhibited the up-regulation (74). In vivo, following four weeks of exercise 
training with or without vitamin E and C supplementation, the exercise induced expression of 
PGC-1α was blunted with antioxidants (116). Another well-known activator of PGC-1α is 
p38 mitogen-activated protein kinases (p38 MAPK) (20). Contraction induced activation of 
p38 MAPK seem to be dependent on ROS production (159). Considering its strong 
expression in muscle tissue and the multiple functions of mitochondria, PGC-1α has received 
a lot of attention in the context of performance and health (35). 
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In the elderly, however, training seems to have a lower effect on PGC-1α protein content 
(88). This may be due to a generally low content in the elderly (79) or impairment in AMPK 
activation (113). In either case, over expression of PGC-1α in skeletal muscle of aged mice 
improved oxidative capacity, suppressed mitochondrial degradation, and prevented muscle 
atrophy (149). 
Seemingly, there are many reasons to investigate PGC-1α in several different settings and 
populations. Although much research is performed, more is needed regarding the regulation 
of PGC-1α and the consequences from it. 
1.2 TRAIN LOW 
Availability of endogenous or exogenous carbohydrates is crucial for performance at 
submaximal or intermittent intensity, with duration over approximately 90 minutes. Based on 
that, the traditional recommendation for athletes has been a high carbohydrate intake, even 
during training periods. However, more recent research has questioned this strategy. Studies 
show little benefit of training with high carbohydrate intake (29). Ingestion of carbohydrates 
during exercise seems to blunt expression of genes involved in FA metabolism rather than 
stimulate those involved in carbohydrate metabolism (37). Instead, it has been suggested that 
training with low carbohydrate availability shifts substrate utilization towards FA, which will 
preserve glycogen stores and thereby increase performance. Mitochondrial density is 
associated with fat oxidation (69) and it is therefore possible that increased fat utilization may 
stimulate mitochondrial biogenesis. 
Exercise increases gene expression of several metabolic genes that promote endurance 
adaptations. Depending on several factors, like exercise mode and substrate availability, the 
increase differs in size and duration (65). One of these genes, PGC-1α, has been linked to 
carbohydrate availability. As mentioned previously, PGC-1α is activated by AMPK and p38 
MAPK, which are activated by carbohydrate-restricted exercise (39, 157). Increased AMPK 
activation following low glycogen exercise may be explained by increased AMP/ATP ratio 
due to low substrate availability. Another explanation is a quite recently discovered glycogen 
binding site on the AMPK β subunit (95). Glycogen inhibits AMPK by binding to it. When 
glycogen is metabolized, AMPK is released and available for activation. In addition, when 
restricting carbohydrate intake during recovery from glycogen depleting exercise, PGC-1α 
gene expression was prolonged (110). Therefore, PGC-1α expression is most likely affected 
by the glycogen levels when performing exercise. 
A groundbreaking study in this area was performed by Hansson and colleagues (61). They 
performed a study in which the subjects trained one leg with normal glycogen levels, and the 
other with half of the sessions performed in a reduced glycogen state. Exercise performance 
and CS activity improved profoundly in the glycogen reduced leg compared to the normal 
leg. This study was followed by training studies using a whole body approach, with subjects 
training twice every other day or once every day. Although these studies found improvements 
in the mitochondrial markers citrate synthase (CS), hydroxyacyl-CoA dehydrogenase (HAD) 
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and succinate dehydrogenase (SDH) (98, 157), none could confirm an improved 
performance. A common feature for these studies is a relatively small difference in glycogen 
between groups (98, 157). It is therefore difficult to interpret if the mitochondrial biogenesis 
is related to glycogen, or something else. Train low is a promising concept that needs further 
investigation; to pinpoint the cause of potential effects, studies with clear differences in 
glycogen levels are needed. 
1.3 CONCURRENT EXERCISE 
The combination of strength and endurance training is often referred to as concurrent 
training. Although there are gaps to fill, the positive effect of adding strength to endurance 
training on endurance performance has been extensively investigated (119). Mainly, there 
seems to be a performance enhancing effect by improved exercise economy, possibly 
mediated by improved strength and power, altered neuromuscular function, and muscle fiber 
type switching towards a more enduring composition. There are discrepancies regarding the 
effect on power output and velocity at the lactate threshold (119). Regarding mitochondrial 
biogenesis, the majority of studies show no benefit when strength and endurance sessions are 
separated by several hours or days in subjects with low or moderate training levels (19, 22, 
64). 
However, when strength and endurance training are performed together in a single session, 
the results are contradictory. Sale and colleagues showed an increased CS activity (26%) in 
the group performing concurrent exercise compared to no effect in endurance training only 
(123). A second study from Sale and colleagues found a similar increase in both groups 
(124). In contrast, Nelson and colleagues found a profound blunting effect on both CS 
activity and VO2max from concurrent exercise training. A possible explanation for this may 
be the load of the strength training. Nelson used a much higher load (3 x 6 repetition 
maximum (RM)) compared to the studies by Sale (6 x 15–20 RM). In addition, Nelson et al 
had the subjects perform strength training prior to endurance exercise, opposite to Sale et al. 
All three studies were performed in recreationally active subjects. 
In an acute crossover study performed at our laboratory, PGC-1α mRNA was vastly 
increased following concurrent exercise. Recreationally active subjects performed an exercise 
session of cycling followed by either rest or a strength training session (60–70% 1RM, <15 
reps). After the concurrent exercise session, mRNA expression of PGC-1α was about twofold 
higher compared to endurance exercise alone (146). The increased gene expression might be 
mediated by increased mammalian target of rapamycin (mTOR) phosphorylation (146). 
mTOR seems important for PGC-1α gene expression; when blocking mTOR with rapamycin 
in skeletal muscle tissue, PGC-1α gene expression decreased (41). 
It seems that concurrent exercise has the potential to both increase and decrease 
mitochondrial biogenesis depending on exercise set up. It is therefore important to find out 
what factors decide the outcome and identify the optimal strategy. It is also important to carry 
  7 
out the research in a trained population that is in the most need of alternative training 
strategies. 
1.4 RESISTANCE TRAINING IN THE ELDERLY 
A negative consequence of aging is a decrease in aerobic capacity. The most widely used 
measure of aerobic capacity, VO2max, starts to decline at about 30 years. After 40 years it 
declines with about 10% per decade and after 70 years the decline is even more pronounced 
(51). The major factor explaining the age-related decline in VO2max is most likely a decline 
in maximal heart rate, which is not related to physical inactivity (32). Other factors such as 
reduction in stroke volume, total blood volume, and muscle O2 extraction may also contribute 
to the age-related decrease in VO2max. However, when normalized to fat-free mass (FFM), 
these parameters seem to be influenced by physical inactivity rather than the aging process 
itself (18, 32). 
Mitochondrial density and maximal respiration are also reduced in the elderly, probably to a 
large extent caused by physical inactivity (109). Mitochondrial dysfunction has also been 
implicated as a central part of the ageing process (109). According to the mitochondrial 
theory of aging, increased mitochondrial production of reactive oxygen species results in 
DNA mutations, which initiates apoptosis and leads to reduced mitochondrial density and 
function (109). In addition, mitochondrial dysfunction has been suggested to play a central 
role in several age-related health impairments like sarcopenia (106), insulin resistance, T2D 
(135) and cardiovascular disease (104). Therefore, it is highly desirable to find strategies to 
counteract/prevent mitochondrial dysfunction and thereby the associated health impairments. 
A well-known strategy to improve VO2max and induce mitochondrial biogenesis in both 
young and the elderly is endurance exercise (68, 96). The effect of resistance exercise on 
these parameters is less investigated, especially in aged subjects. Since VO2max and 
mitochondrial function is reduced in the elderly, especially individuals with low physical 
activity levels, resistance training may have a more beneficial effect compared to that in the 
young. Some, but not all (31), studies show a positive effect on VO2max (52, 152). Regarding 
mitochondrial density, several studies have investigated the effect but the results are 
conflicting (11, 47, 52, 139). 
1.5 INSULIN SENSITIVITY 
The ability of the body to lower blood glucose levels in response to insulin is referred to as 
whole body insulin sensitivity. Physical inactivity, obesity and a poor diet may reduce the 
ability to dispose glucose from the blood. If glucose uptake is reduced below a certain level, 
impaired glucose tolerance develops, which is also referred to as pre-diabetes. Skeletal 
muscle accounts for approximately 80% of glucose disposal, which makes the muscle tissue a 
major player for regulating blood glucose levels. The first stage of developing T2D involves a 
reduced ability of muscular tissue to increase glucose uptake in response to insulin. To 
maintain blood glucose homeostasis, the body responds by increasing insulin excretion from 
pancreatic beta cells. As the insulin resistance progresses, insulin excretion amplifies. As 
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endogenous insulin becomes unable to maintain glucose homeostasis, diabetes develops. In 
the last stage of diabetes, beta cells become exhausted and the pancreas loses its ability to 
produce insulin. 
The interference between carbohydrate and fat uptake and oxidation has been investigated for 
many decades. In 1963 Randle and colleagues showed that fatty acids (FA) impaired insulin-
mediated glucose uptake by inhibiting pyruvate dehydrogenase (112). Since then several 
studies have connected insulin resistance to fat metabolism. Increased lipolysis, plasma FA or 
intra myocellular triglycerides (IMTG) are common features of many conditions associated 
with reduced insulin sensitivity, e.g. obesity, T2D, lipid infusion (10), high-fat diet (10, 78) 
and starvation (78). One theory suggests that an accumulation of IMTG causes insulin 
resistance. Much research has been performed in this area and there is a strong connection 
between increased IMTG and insulin resistance (143). The impairing effect seems to be 
mediated by toxic lipid intermediates, e.g. diacyl glycerols (DAG) and ceramides, that 
interfere with insulin signaling on several levels (143). Although the theory is supported by 
mounting evidence, it seems the connection is quite complex. Muscular contents of IMTG, 
DAG and ceramides are also increased in highly insulin sensitive endurance athletes, a 
contradiction referred to as “the athlete’s paradox” (3). 
In addition to having an increased level of IMTG, several studies show that individuals with 
insulin resistance or T2D have reduced mitochondrial content and function (143). Based on 
these observations it has been suggested that inherited or acquired mitochondrial dysfunction 
compromises the ability to oxidize fat. This may in turn cause IMTG accumulation and 
insulin resistance (125). Despite a large body of evidence, the theory has been questioned. 
Studies finding mitochondrial impairments in diabetics and insulin-resistant individuals have 
been criticized for not considering physical activity (121). When comparing healthy controls, 
pre-diabetics and longstanding T2D individuals, mitochondrial dysfunction was only found in 
the latter. This indicates that mitochondrial dysfunction develops during diabetes rather than 
precedes it. When the subjects then performed exercise training for a year, several of the 
mitochondrial impairments were reversed (144). In addition, muscles have a large spare 
oxidative capacity to use at high-intensity activities (12); the small reductions seen in insulin-
resistant individuals are therefore not likely to compromise fat oxidation during low to 
moderate intensities in everyday living. Therefore, mitochondrial dysfunction is related to 
physical inactivity and likely not causative of insulin resistance. 
Several studies have also contradicted the theory that mitochondrial dysfunction precedes 
insulin resistance and laid a platform for an alternative theory. Rodents fed a high-fat diet 
induce insulin resistance while increasing fat metabolism (142). In addition, inhibition of FA 
uptake into mitochondria prevents high-fat diet induced insulin resistance (86). It is possible 
that increased, instead of reduced, fat metabolism contributes to insulin resistance. Increased 
fat metabolism stimulates the production of ROS (7, 128) and there is a strong connection 
between ROS and insulin resistance (71, 103). Even more important, blocking mitochondrial 
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Figure 2. Inhibition of Insulin stimulated glucose uptake by FA and ROS. FA, fatty acid; IR, 
insulin receptor; GLUT4, glucose transporter 4; GS, glycogen synthase; AS160, Akt 
substrate of 160 kDa; ROS, reactive oxygen species; DAG, diacyl glycerols; SCFA, short 
chain fatty acid; MCFA, medium chain fatty acid; LCFA, long chain fatty acid; CPT-1, 
Carnitine palmitoyltransferase I; ACC, Acetyl-CoA carboxylase; BOH, β-hydroxybutyrate.   
 
Although mitochondrial dysfunction may not cause insulin resistance, improving 
mitochondrial function through exercise may improve insulin resistance. Increasing 
mitochondrial density by exercise utilizes substrate oxidation towards fat (69). An improved 
ability to oxidize fat will make it easier to handle increased levels of fatty acids and may 
thereby prevent insulin resistance. In addition, it is well known that exercise training reduces 
oxidative stress and up-regulates anti-oxidative defenses (48, 105). An improved ability to 
chronically maintain the redox homeostasis may be one of the mechanisms behind improved 
insulin sensitivity following training. Endurance exercise has for long been recognized as an 
efficient method to prevent insulin resistance in both young and old (88). Resistance exercise 
has been proven to improve insulin sensitivity in younger adults (<65 years) (133) and the 
elderly with impaired glucose tolerance (73, 126). In healthy elderly (>65 years) studies are 
contradictory (44, 158) and there is need for further research. 
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PGC-1α may also play a role in insulin sensitivity. The finding that PGC-1α gene expression 
is reduced in diabetics (107) has led to the assumption that PGC-1α may be important for 
insulin sensitivity. However, genetically engineered mice contradict this hypothesis. When 
PGC-1α is over expressed, high-fat diet induced insulin resistance actually worsens (50). In 
contrast, exercising seems to be more insulin sensitizing in these mice compared to wild type 
mice (134). Although these findings show an involvement of PGC-1α in insulin sensitivity, 
its role is far from established. 
1.5.1 Starvation 
It is well established that short-term starvation in humans induces insulin resistance (93). 
Starvation may well be one of the earliest, if not the first, forms of insulin resistance in 
humans. Elucidation of the mechanisms involved in this form of insulin resistance could 
therefore have implications for understanding the development of insulin resistance under 
other conditions, such as obesity and T2D. 
Within 24 hours of starvation, liver glycogen is depleted (101) and thereafter insulin 
resistance develops in peripheral tissues. The reduced insulin sensitivity is an important 
physiological response to prioritize glucose for the central nervous system. Since exercise 
acutely stimulates both insulin-dependent and insulin-independent muscle glucose uptake 
(53, 120), there is a potential danger that exercise during a hypoglycemic state may 
compromise metabolic homeostasis. The effect of acute exercise on insulin sensitivity during 
starvation is, however, unclear and further studies are required. 
Starvation is associated with increased lipolysis, and increases in plasma FA and IMTG 
(132). As mentioned previously, increased lipid accumulation and metabolism induce insulin 
resistance, possibly mediated by ROS. In addition, starvation, or rather carbohydrate 
deprivation, induces production of lipid-derived ketone bodies. Since untreated T2D results in 
carbohydrate deprivation on a cellular level, increased ketone bodies is a common feature. 
Ketone bodies reduce insulin sensitivity (156) and it is possible they play a role in the 
development of insulin resistance (4). 
Starvation seems to reduce mitochondrial respiration in humans (67) and reduce ROS 
production in mice (127). However, more research is needed to fully understand the 
adaptation of the mitochondria to food deprivation.  
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2 AIMS 
The overall aim of this thesis is to provide increased knowledge of how different exercise 
strategies improve performance and insulin sensitivity. The mitochondria represent a central 
part of this thesis considering their key role in health and performance. To be more specific, 
the aims were: 
 
 To examine the effects of endurance exercise with low muscle glycogen on markers 
of mitochondrial biogenesis. 
 
 To examine the effect of concurrent strength and endurance training on markers of 
mitochondrial density and aerobic capacity. 
 
 To examine the effect of exercise during starvation on insulin sensitivity. 
 
 To examine the effects of resistance exercise training in the elderly on insulin 
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3 MATERIAL AND METHODS 
3.1 SUBJECTS 
In Study I, the subjects were highly trained male cyclists with a history of competing at the 
national level. In Study II, the subjects were moderately trained male cyclists. In Study III, 9 
recreationally active students participated in the study. In Study IV, 21 elderly (65-79 years) 
men and women with low physical activity level participated. One subject had a pacemaker 
(CON group), one asthma (RET group) and one was in an early stage of Parkinson’s disease 
(RET group). The subjects with asthma and pacemaker were excluded from the submaximal 
cycling test. Subject characteristics are shown in table 1.  
All subjects were informed about the possible risks and discomforts involved in the 
experiment prior to giving their written consent to participate in the study. The study design 
was approved by the Regional Ethics Committee of Stockholm, Sweden. 
 





Study I 0/10 27.8 ± 1.6 65 ± 1 
Study II 19 34.7±1.2 56±1 
Study III 4/5 23.2 ± 0.5 46 ± 2 
Study IV 11/10 71.7 ± 0.8 - 
Table 1. Subject characteristics. 
 
3.2 INTERVENTION PROTOCOLS 
3.2.1 Study I 
Subjects participated in two experimental sessions in a crossover design with a high (normal 
glycogen, NG) or a low carbohydrate diet (low glycogen, LG). Both sessions included two 
exercise tests separated by about 14 h. The purpose of the first exercise session was to deplete 
muscle glycogen (depletion exercise) and the second exercise session to test the influence of 
low muscle glycogen on the exercise response (test exercise). The depletion exercise started 
with 45 min cycling at 75 % VO2max followed by eight intervals at 88 % VO2max (duty 
cycle 4 min exercise and 4 min active rest at 100 W), and ended with an additional 45 min at 
70 % VO2max. The test exercise included six intervals of 10 min cycling with 4 min active 
rest (100 W) between intervals. The first interval was at 72.5 % VO2max after which the 
work rate was reduced 2.5 % during each interval (last interval 60 % VO2max) (Fig. 3). 
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Figure 3. Schematic illustration of the experimental design. B beverages containing CHO 
(NG normal glycogen) or only water (LG low glycogen). Meals contained either high (NG) 
or low CHO (LG). Beverages and meals post-exercise were separated by *1 h intervals and 
the beverages served during exercise were consumed ad libitum. Muscle biopsies and venous 
blood samples were obtained approximately 15 min before the depletion (S1) and test 
exercise (S2) as well as 3 h after the test exercise (S3).  
 
3.2.2 Study II 
The subjects were divided into an endurance training group (E, n=10) or an endurance + 
strength training group (ES, n=9). They were instructed to continue their habitual cycle 
training but to exchange two ordinary training sessions per week with supervised laboratory 
training. The training consisted of 60 min of continuous cycling starting at a work rate 
corresponding to 90% of the mean power output during TT40 in the pre-test and then 
increasing to 95% throughout the intervention period. The strength training was performed in 
a leg press machine and consisted of a warm up set with 10 repetitions at 50% of 1 RM 
(determined in pre-test) followed by sets at 65, 70, 75, 75, 70, and 65% of 1 RM. Instead of 
resistance exercise the E group cycled for 2.5-4 min corresponding to an equal amount of 
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Figure 4. Schematic illustration of the experimental protocol. LT4, 4 mmol l
-1
 lactate 
threshold test; RT, resistance training session, TT40, 40 min time trial; 1RM, one repetition 
maximum. 
 
3.2.3 Study III 
Subjects participated in two experimental sessions separated by at least two weeks in a 
crossover design with randomized order. Both sessions included 75 h starvation with only 
water; in one of the sessions subjects performed an acute bout of exercise consisting of 5 x 10 
min intervals separated by 2-4 min rest starting at 70% VO2max. To avoid fatigue and be able 
to complete the exercise session, the intensity had to be gradually reduced to 50% VO2max 
on the last interval (Fig. 5). 
 
 
Figure 5. Schematic illustration of the experimental protocol. w/wo Ex, with/without 
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3.2.4 Study IV 
The subjects were divided into a resistance exercise training group (RET) or a control group 
(CON). The RET group performed 3 supervised sessions per week for 8 weeks. Each session 
started with a warm up and then the subjects performed exercises activating all major muscle 
groups (seated leg press, leg curl, leg extension, seated row, abdominal crunches, shoulder 
press and chest press). Each exercise was performed in 3 sets at 75-80 % of 1RM. If a subject 
was able to complete 12 repetitions in all sets of an exercise the load was increased ~5 % 
until next session. 
3.3 PHYSIOLOGICAL TESTS 
3.3.1 VO2max (Study I, II and III) 
The testing of VO2max was performed on an ergometer (Monark 839E, Monark Exercise, 
Varberg, Sweden or SRM, Konigskamp, Germany) with a two stage incremental exercise 
protocol. The first part (3-5 min cycling at 5-6 submaximal intensities) was used to establish 
the relation between VO2 and work rate (W) and to get a rough estimate of the work rate 
corresponding to VO2max. After 3-5 min active rest, the work rate was increased rapidly until 
voluntary exhaustion with a protocol designed to elicit VO2max after 7–8 min. Oxygen 
uptake was measured using an online system (Oxycon Pro, Erich Jaeger, Hoechberg, 
Germany or AMIS 2001; Inovision A/S Odense, Denmark) and VO2max was defined as the 
highest recorded oxygen uptake during 40-60 consecutive seconds. The following criteria 
were used for attaining VO2max: rating of perceived exertion (RPE) > 18, respiratory 
exchange ratio (RER) > 1.1, and a plateau of VO2 with increased workload. 
3.3.2 Lactate threshold (Study II) 
The work rate corresponding to 4 mmol lactate per l blood (LT4) was determined during 
incremental submaximal exercise (the first part of the two stage VO2max protocol). Capillary 
blood samples were collected from the finger tip immediately after each submaximal 
intensity and analyzed for lactate. 
3.3.3 Time trial 40 min (TT40) and 30 s sprint tests (Study II) 
The TT40 was performed on an ergometer (SRM, Konigskamp, Germany), preceded by 
warm up for 10 min.  To standardize the test, subjects received information about the pacing 
strategy that they used during the preliminary test and were instructed to repeat this during 
the pre- and post-test. Subjects completed TT40 without any feedback other than the 
remaining time. Power output, cadence and heart rate were measured continuously. After the 
TT40 subjects had a total of 20 min of easy pedaling (~70W) followed by a 30 s maximal 
isokinetic sprint at 115 rpm in an “all out” fashion (Wingate test) with strong verbal 
encouragement. The sprint was performed seated and the subjects were informed of every 10 
sec elapsed. Peak power was defined as the highest mean power output during 0.5 sec at any 
time during the sprint. 
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3.3.4 HR and RER during steady state cycling (Study IV) 
In Study IV another measurement of endurance capacity was used considering the frailty of 
the subjects. Endurance capacity was established by measuring HR and RER during an 
exercise session on a cycle ergometer. The test consisted of two submaximal 4 min intervals 
with no rest between. The first interval was performed at a standard work rate (30 W) and the 
second at an individually based work rate (60-120 W). Mean HR and RER was calculated 
from the last minute of the intervals. 
3.3.5 Strength and power (Study IV) 
Knee extensor strength was measured as peak torque output during maximal voluntary 
isometric, concentric and eccentric right leg knee extension performed in a seated position 
using an isokinetic dynamometer (Isomed 2000, D&R, Hemau, Germany). The test was 
preceded by a warm up and several familiarization trials. During the test the subject 
performed four maximal voluntary eccentric and concentric knee extension actions 
(alternately) of the right leg at an angular velocity 30 deg • s-1 through a range of motion of 
90 to 15° (0° = straight leg). After 4 minutes of rest four static measurements were made, at a 
knee angle of 65° (0° = straight leg). Torque signals were converted from analog to digital 
signals at 5 kHz using a CED 1401 data acquisition system and Signal software (Cambridge 
Electronic Design, Cambridge, UK). For each subject the test trial with the highest peak 
torque of the eccentric, concentric and static assessments, respectively, was used. Rate of 
torque development (RTD) was determined from the trial with maximal voluntary static 
contraction (MVC). RTD was derived as the mean slope of the torque-time curve 
(Δtorque/Δtime, unit Nm/s) over the time intervals 0-30 ms and 0-200 ms. Onset of 
contraction (time 0 ms) was defined as the time when knee extensor torque exceeded the 
baseline torque by 7.5 Nm. 
3.3.6 1RM (Study II and IV) 
The test started with a brief warm up set in the tested exercise. Thereafter the load was 
increased to near below an estimated 1RM. The subject performed 1 repetition and then the 
load was increased ~5 %. After sufficient recovery the procedure was repeated until failure.  
The highest load where 1 repetition could be performed was determined to be 1 RM. 
3.3.7 Insulin sensitivity (Study III and IV) 
In study III insulin sensitivity was measured with an intravenous glucose tolerance test 
(IVGTT) and in study IV with an oral glucose tolerance test (OGTT). Both tests were 
performed at least 48 h following exercise and 12 h following a meal. For the IVGTT venous 
cannulae were inserted into the antecubital vein of each arm. One arm was used for glucose 
infusion and the other for blood sampling. Basal samples were collected at 15 and 5 min prior 
to glucose infusion. Glucose was infused with a continuous flow over two minutes (0.3 g kg
-1
 
body weight) after which blood samples were then collected at 1, 2, 3, 4, 5, 8, 10, 15, 20, 30, 
40, 60 and 90 min following glucose infusion. The cannula was flushed frequently with saline 
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to avoid blood clotting. The samples were centrifuged at 1 500 g at 4°C for 10 min and 
plasma stored at -20°C for later analysis. Glucose tolerance was calculated as the area under 
the glucose curve above basal (AUCglucose) and glucose disappearance rate (Kg) as the slope of 
the logarithmic glucose concentrations between 10 and 40 min. The method by galvin, SIgalvin 
(54), was used as a measure of whole body insulin sensitivity and was calculated as the ratio 
of Kg over the area under the insulin curve from 0 to 40 min above basal. Insulin release was 
measured as the area under the plotted curve above basal between 0 and 40 min (AUCinsulin 0 – 
40 min). Acute insulin response was calculated as the ratio between the areas under the curves 
for insulin and glucose above basal during the initial period (0 –10 min). 
For the OGTT venous cannulae were inserted into the antecubital vein of one arm. Basal 
samples (4 ml) were collected at 15 min and immediately prior to glucose load (75 g glucose 
in a 250 g l
-1
 solution). Blood samples were then collected at 15, 30, 60, 90 and 120 min 
following glucose intake. The samples were centrifuged at 1 500 g at 4°C for 10 min and 
plasma stored at -20°C for later analysis. Area under the curve (AUC) for glucose, insulin 
and c-peptide was defined as the area under the curve above basal levels. Whole body insulin 
sensitivity was calculated with the Matsuda method (94) as 
10,000*√[(Glucosebasal*Insulinbasal)*(Glucosemean*Insulinmean during OGTT)]. 
3.4 ANALYTICAL METHODS 
3.4.1 Blood sampling (Study I-IV) 
Blood samples were collected from an anticubital vein (4 ml) and centrifuged at 1 500 g at 
4°C for 10 min and plasma stored at -20°C for later analysis. To determine plasma FFA 
concentration a commercially available colorimetric enzymatic procedure (NEFA C test kit; 
Wako Chemicals GmbH, Neuss, Germany) was used (Study I and III). Venous plasma 
concentrations of Cortisol (Study II), Testosterone (Study II), Insulin (Study I, III and IV) and 
C-peptide (Study IV) were determined with commercially available ELISA kits (cortisol and 
testosterone, Calbiotech, CA, USA; insulin and c-peptide, Mercodia, Uppsala, Sweden). All 
plates were analyzed in a plate reader (Tecan infinite F200 pro, Männedorf, Switzerland). 
Glucose was analyzed in plasma and lactate in whole blood using an automated analyzer 
(Biosen 5140, EKF Diagnostics, Barleben, Germany). 
3.4.2 β-hydroxybutyrate (BOH) (Study III) 
The concentration of BOH in blood was analyzed with an enzymatic technique (55). Blood 
was mixed (2:1) with perchloric acid (0.65 M) and stored on ice. The sample was centrifuged 
at 3 000 g for 15 min, and the blood supernatant was stored at -80°C. One milliliter of 
supernatant was mixed with 0.1 ml K2CO3 (3.6 M) and incubated at 0°C for 5 min. The 
sample was centrifuged at 1 400 g for 30 s, the supernatant was transferred to another 
eppendorf tube, and pH was checked (pH 9.5). A 96-well plate was loaded with the samples 
and mixed with a reagent solution (4:1) consisting of glycine (330 mM), NAD (7.9 mM), and 
malate dehydrogenase (82 μg ml-1). The absorbance was measured after 10 min at 340 nm 
with a plate reader (Tecan infinite F200 Pro; Tecan, Männedorf, Switzerland). Then, 5 μl of 
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sodium β-OH dehydrogenase (17 U ml-1) was added to each well, and the absorbance was 
measured after 30 min when the reaction was finished. The concentration of BOH was 
calculated from the change in absorbance using a concentration curve. 
3.4.3 Muscle sampling (Study I-IV) 
Muscle biopsies were obtained from the middle portion of the vastus lateralis muscle using 
the percutaneous needle biopsy technique with suction (21) (Study I-III) or a Weil Blakesley 
conchotome (Wisex, Mölndal, Sweden) (Study IV). For histochemistry the samples were 
frozen in isopentane cooled to its freezing point in liquid nitrogen and stored at -80°C. For 
other analyses the samples were rapidly frozen in liquid nitrogen and stored at -80°C. Later 
the samples were freeze-dried, dissected free of blood and connective tissue and then 
homogenized in ice-cold medium specific for each analytical method. 
3.4.4 Gene expression (Study I) 
For mRNA analysis, total RNA was extracted from 2–5 mg freeze-dried muscle tissue using 
a Polytron PT 1600 E homogenizer (Kinematica, Lucerne, Switzerland) and a PureZOL RNA 
isolation kit according to the manufacturer’s instructions (Bio-Rad Laboratories AB, 
Sundbyberg, Sweden). The yield and quality of extracted RNA were estimated by 
spectrometry and micro-gel electrophoresis (Experion, Bio-Rad). The 260/280 absorbance 
ratios were within 1.9–2.1 (in Tris–EDTA buffer, pH 8.0) and the RNA quality indicator 
values (RQI) were greater than 0.7. RNA (1 μg) was reverse transcribed to cDNA (20 μl) 
using the iScript cDNA synthesis kit (Bio-Rad). Real-time polymerase chain reaction (RT-
PCR) was performed with an iCycler (Bio-Rad) in a mixture containing 12.5 μl 29 SYBR 
Green Supermix (Bio-Rad), 0.5 μl of both the forward and reverse primers (final 
concentrations 10 μM), and 11.5 μl template cDNA. All reactions were performed in 
triplicate with GAPDH as reference gene (91). The melting curves of the PCR product 
showed only one peak, demonstrating specificity of the primers and absence of 
contamination. The cDNA concentration, annealing temperature and thermocycling 
conditions were optimized for each primer pair, and assay sensitivity was high for all PCR 
products (RSq [0.99, and efficiency [90 %). The comparative critical threshold (CT) method 
could therefore be used to calculate changes in mRNA levels. 
3.4.5 Glutathione analysis (Study I) 
Glutathione in reduced (GSH) and oxidized (GSSG) form were determined with the 
Bioxytech GSH/GSSG-412 assay (Oxis Research, Foster City, CA, USA). The freeze-dried 
muscle tissue was divided into two aliquots and homogenized using glass homogenizers in 
ice-cold buffer (80 μl mg-1) containing (in mM): Tris buffer (10), EDTA (1), EGTA (1), Na-
orthovanadate (2), Na-pyrophosphate (2), NaF (5) and protease inhibitor cocktail, with or 
without 1-methyl-2-vinylpyridinium trifluoromethanesulfonate (M2VP), a scavenger of 
reduced GSH. Following 5 min incubation with 1 % Triton X-100 (room temperature for 
M2VP aliquot and ice cold for the M2VP free aliquot), 5 % metaphosphoric acid was added 
and the aliquots were centrifuged at 13 000 g for 10 min. The supernatant (5 μl) was diluted 
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1:20 with homogenization buffer and 100 μl chromogen, glutathione reductase and NADPH 
was added, followed by spectrophotometric measurement of the change in absorbance at 412 
nm over 3 min. Reduced GSH was calculated from the measurements of total GSH (without 
M2VP in homogenate) and GSSG (with M2VP in homogenate). GSSG values are expressed 
in GSH units, i.e. 1 GSSG = 2 GSH. 
3.4.6 Citrate synthase (CS) and Hydroxyacyl-CoA dehydrogenase (HAD) 
enzyme activity (Study II) 
For determination of enzyme activity, muscle samples were homogenized using a bullet 
blender in a buffer (150 µl mg
-1
) with the following composition (in mM): 50 K2HPO4, 1 
EDTA and 0.05% Triton X-100 adjusted to pH 7.4. The homogenate was centrifuged at 10 
000 rpm for 10 min and the supernatant was collected and diluted x3. CS activity was 
measured in a reagent solution (in mM): 50 Tris-HCl, 0.2 DTNB and 0.1 acetyl-CoA. The 
reaction was initiated by adding oxaloacetate (7 mM) and the change in absorbance at 412 
nm was measured spectrophotometrically at 25°C. HAD activity was measured in a reagent 
solution (in mM): 65 Triethanolamine HCL, 0.3 EDTA and 0.3 NADH adjusted to pH 7.0. 
The reaction was initiated by adding acetoacetyl coenzyme A (4 mM) and the change in 
absorbance at 340 nm was measured spectrophotometrically at 25°C. 
3.4.7 Western blot (Study I-IV) 
The samples were homogenized using a bullet blender (Bullet Blender 1.5, Next Advance, 
NY, USA) in ice-cold buffer (80 µl mg
-1
) with the following composition (in mM):  2 
HEPES, 1 EDTA, 5 EGTA, 10 MgCl2, 50 β-glycerophosphate, 1% TritonX-100, 1 Na3VO4, 
2 Dithiothreitol, 20 μg ml-1 Leupeptin, 50 μg ml-1 Aprotinin, 1% Phosphatase inhibitor 
cocktail (Sigma P-2850, St Louis, MO, USA), 40 μg μl-1 PMSF. In Study I-III the 
homogenate was centrifuged to pellet the insoluble debris, centrifugation was not performed 
in Study IV to avoid the possibility of losing proteins of interest. Protein concentration was 
determined with the bicinchoninic acid assay (Pierce Biotechnology, Rockford, IL, USA) by 
measuring the absorbance at 560 nm with a plate reader (Tecan infinite F200 pro, Männedorf, 
Switzerland). The samples were diluted with Laemmli sample buffer (Bio-Rad Laboratories, 
Richmond, CA, USA) and homogenizing buffer (1:1) to a final protein concentration of 1.5 
µg µl
-1
 and heated to 95°C for 5 min to denature proteins. The diluted samples were stored at 
-20°C prior to analysis. The proteins of the diluted samples were separated by SDS-PAGE 
(Criterion cell gradient gels, Bio-Rad Laboratories) for 45 min at 300 V on ice and then 
transferred to polyvinylidine fluoride membranes (Bio-Rad Laboratories) for 3 h at 300 mA 
on ice. The amount of protein loaded to the membranes was kept constant for all samples and 
was verified by staining with MemCodeTM Reversible Protein Stain Kit (Pierce 
Biotechnology). After blocking for 1 h at room temperature in 5% non-fat milk, the 
membranes were incubated over night with primary antibodies (see specific study). This was 
followed by 1 h incubation with anti-rabbit or anti-mouse HRP (1:10 000) as secondary 
antibody. The antibodies were visualized by chemiluminescent detection on a Molecular 
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Imager ChemiDocTM XRS system and the bands were analyzed using Quantity One® 
version 4.6.3 software (Bio-Rad Laboratories).  
3.4.8 Mitochondrial respiration and ROS emission (Study I and III) 
Muscle samples (10-25 mg wet weight) were stored in an ice cold medium with the following 
composition (in mM): 2.8 CaK2EGTA, 7.2 K2EGTA, 5.8 Na2ATP, 6.6 MgCl2, 20 Taurine, 15 
Na2Phosphocreatine, 20 Imidazole, 0.5 Dithiothreitol and 50 MES adjusted to pH 7.1. The 
specimen was split into 2-5 mg fiber bundles and each bundle was mechanically separated 
using surgical needles into a network formation to expose fiber membranes to the 
surrounding medium. The bundles were incubated with saponin (50 µg ml
-1
), washed twice 
and stored in a medium with the following composition (in mM): 0.5 EGTA, 3 MgCl2, 60 K-
lactobionate, 20 Taurine, 10 KH2PO4, 20 Hepes, 110 Sucrose and 1 g l
-1
 BSA adjusted to pH 
7.1.  
Mitochondrial respiration was measured with either a Clark-type electrode (Hansatech 
instruments, Kings Lynn, England) (study I) at 25°C or an Oroboros oxygraph (Oroboros 
Instruments, Innsbruck, Austria) (study III) at 37°C in the storage medium. Oxygen level in 
chamber was adjusted to 400 nmol ml
-1
 with H2O2 and 280 U ml
-1
 Catalase. To reduce 
muscle contractions 45 µM Benzyltoluene sulfonamide was added (108). For measurement 
protocol, see separate study.  
The rate of mitochondrial H2O2 production was measured with Amplex red (Invitrogen, 
Eugene, OR, USA), which, in the presence of peroxidase enzyme, reacts with H2O2 and 
produces the red fluorescent compound Resorufin. Permeabilized fiber bundles were added to 
the measuring medium (in mM): Mannitol (225), Sucrose (75), Tris-base (10), K2HPO4 (10), 
EDTA (0.1), MgCl2 (0.08), 2 g l
-1
 BSA, 13.5 U ml
-1
 Horse radish peroxidase, 45 µM 
Benzyltoluene sulfonamide, 45 U ml
-1
 SOD and 2 μg ml-1 Oligomycin, adjusted to pH 7.1 
and kept at 30 °C. The change in fluorescence was recorded (Hitachi fluorescence 
spectrophotometer f-2500 with magnetic stirrer, Tokyo, Japan). For measurement protocol, 
see separate study. 
3.4.9 Glycogen (Study I and III) 
Glycogen was analyzed in 1-2 mg of freeze-dried muscle according to the method previously 
described by Harris et al (62), which includes enzymatic hydrolysis of glycogen followed by 
enzymatic analysis of glucose. 
3.4.10 Histochemistry (Study IV) 
Serial 10 μm-thick cross sections were cut at -20°C using a cryostat (Leica CM1950; Leica 
Microsystems, Wetzlar, Germany). The sections were then mounted on glass slides and air 
dried at room temperature. The sections were stained for myofibrillar ATPase at pH 9.4 after 
preincubation at pH 4.36, 4.65 and 10.37 (27). To visualize capillaries, the cross-sections 
were stained by the amylase-PAS method (6). One region of the cross section without 
artifacts and no tendency to longitudinal cuts of the fiber were selected and analyzed in a light 
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microscope (Olympus BH-2, Olympus, Tokyo, Japan) using Leica software (Leica Qwin V3, 
Leica Microsystems, Wetzlar, Germany). Fibers were measured for cross sectional area 
(CSA), capillaries and classified as type I, IIA or IIX. 
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4 RESULTS 
4.1 TRAIN LOW 
In Study I, at the initiation of the test exercise, muscle glycogen was significantly lower in 
LG (27 %) compared to NG (74 %). FFA increased in LG with 112 % pre-test exercise and 
290 % post-test exercise. FFA increased in LG with 112 % pre-test exercise and 290 % post-
test exercise. Blood glucose was slightly reduced in both NG and LG, with no difference 
between conditions, and insulin was reduced in LG and slightly elevated in NG (Figure 6). 
Although PGC-1α mRNA increased in both groups 3 h following test exercise, the expression 




Figure 6. Study I. Metabolic responses in (A) muscle glycogen, (B) plasma free fatty acids, 
(C) plasma glucose and (D) plasma insulin. LG, low glycogen; NG, normal glycogen; Values 
are reported as means ±SE (n=10). * P<0.05 and ** P<0.01 vs pre-depletion exercise; ## 











































































































Figure 7. Study I. Effect of exercise on mRNA levels of PGC-1α. LG, low glycogen; NG, 
normal glycogen; Values are expressed as means±SE (n=10). *P<0.05 and **P<0.01 vs 
Pre-depletion exercise; ††P<0.01 vs NG. 
 
4.2 CONCURRENT EXERCISE 
In Study II, VO2max increased similarly in both groups and time to exhaustion during the 
VO2max test increased in ES (+10%). LT4 and mean power output during the 40 min time 
trial increased in E (+3% and +4%, respectively) (Table 2). 
 
 E ES 







) 55±1 58±1** 57±1 58±1* 
TTE- VO2max (s) 402±14 423±15 407±22 443±21** 
LT4 (W) 287±11 295±11* 283±9 286±8 
TT40 (W) 284±11 294±11* 282±10 290±10 
Table 2. Study II. Effect of training on performance and performance related variables. TTE-
VO2max, time to exhaustion during the VO2max test; LT4, work rate corresponding to 4 mmol 
lactate per l blood; TT40, 40 min time trial. E, endurance training only (n=10); ES, 
endurance + strength training (n=9). Values are reported as means ± SE. Main effect of 
training: *; P < 0.05 vs. pre-training; **; P < 0.01 vs. pre-training. 
 
HAD and CS activity was unaffected by concurrent training (+3% and -1%, respectively) and 
endurance training (+11% and +9%, respectively) (Figure 8a and b). Training had no effect 
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Figure 8. Study II. Effect of 8 weeks of training on mitochondrial enzyme activities. E, 
endurance training only (n=10); ES, endurance + strength training (n=9). CS, citrate 
synthase; HAD, 3-hydroxyacyl-CoA dehydrogenase. Values are reported as means ±SE. 
 
4.3 RESISTANCE TRAINING IN ELDERLY 
In Study IV, training resulted in hypertrophy as indicated by increased FFM (+1.4 kg), thigh 
circumference (3.3%) and thigh area (6.7%) in RET. However, fiber CSA did not increase 
(Table 3). 
 
 RET CON 
 Pre Post Pre Post 
FFM (kg) 51.0±2.3 52.4±2.1** 47.6±4.1 48.6±4.3 
Thigh circumference (cm) 48.6±1.2 50.1±1.0***† 46.4±1.6 46.1±1.5 
Thigh CSA (cm
2
) 188±9 200±8***† 155±12 154±11 
Fiber CSA (μm2)     
     Type I 5452±393 5567±362 4889±323 4807±354 


















Table 3. Study IV. Physical characteristics before and after resistance exercise training. 
RET, resistance exercise training (n=12); CON, control (n=9); Fiber CSA: RET (n=10) and 
CON (n=7); FFM, fat free mass; CSA, cross-sectional area. Values are presented as 
mean±SEM.  **p<0.01 vs pre; ***p<0.001 vs pre; † p<0.05 vs CON post; # p<0.05 type II 
























































Strength measured as torque and power as RTD increased following resistance exercise. 
Knee extensor strength improved in RET during isometric (+12%), concentric (+11%), and 
eccentric (+8%) contraction (Figure 9a). RTD during 0-30 ms of the peak MVC increased by 
52%. RTD during 0-200 ms of peak MVC did not change significantly (Figure 9b). For each 
exercise the load during the training period increased significantly (p<0.05) as follows: seated 
leg press +30%, abdominal crunches +61%, chest press +24%, lat spread +38%, shoulder 
press +72%, seated row +58%, leg extension +19% and seated squats +41%. Signaling 
proteins related to muscle protein synthesis, Akt and mTOR, increased by 69% and 69%, 
respectively (Figure 10a and b). 
Histological analysis showed a significant increase from resistance training in the amount of 
type IIa fibers (27 ± 7 %, p<0.005) and a strong trend for decreased amount of type IIx fibers 
(16 ± 18 %, p=0.068) (Figure 11a and b). 
 
 
Figure 9. Study IV. Changes following resistance exercise training in (A) eccentric, static 
and concentric MVC and in (B) RTD during 0-30 ms and 0-200 ms of the peak MVC. RET, 
resistance exercise training (n=12); CON, control (n=9); Values are presented as % ± SEM 
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Figure 10. Study IV. The effect of resistance exercise training on protein levels of total mTOR 
and Akt. RET, resistance exercise training (n=12); CON, control (n=9); Values are 
presented as % ± SEM relative to basal values (mean±SEM). *p<0.05 vs pre; ***p<0.001 vs 
pre; †† p<0.01 vs CON post.     
 
 
Figure 11. Study IV. The effect of resistance exercise training on muscle fiber type 
composition in (A) RET, resistance exercise training (n=12) and (B) CON, control (n=9); 




































































Figure 12. Study IV. Cardio respiratory data pre and post resistance exercise training. (A) 
HR, heart rate and (B) RER, respiratory exchange ratio during low (30 W) and high (60-120 
W) intensity steady state cycling. Two subjects were excluded from the submaximal cycling 
test due to asthma and pacemaker. RET, resistance exercise training (n=11); CON, control 
(n=8); Values are presented as mean±SE. (*) Strong trend vs pre; *p<0.05 vs pre. 
 
During cycling at the lowest intensity interval HR was unchanged in both groups (Fig. 12a), 
however, RER increased in CON (+4.1%) with no change in RET (Fig. 12b). At the highest 
intensity interval there were strong trends for a decrease in heart rate in RET (-4.7%, 
p=0.056) and an increase in CON (+4.6%, p=0.068). RER decreased in RET (-4.0%). Protein 
levels of well known markers for mitochondrial volume, OXPHOS complexes II, IV and CS, 
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Figure 13. Study IV. The effect of resistance exercise training on mitochondrial proteins 
OXPHOS complex II, III, IV and citrate synthase. RET, resistance exercise training (n=12) 
and (B) CON, control (n=9); Values are presented as % ± SEM relative to basal values 
(mean±SEM). **p<0.01 vs pre; † p<0.05 vs CON post; ††† p<0.001 vs CON post.      
 
4.4 STARVATION 
In Study III, plasma levels of BOH increased 50-fold after starvation. Although BOH 
decreased immediately following exercise, it increased to the same levels as NE 3 h post 
exercise. FA increased 3.3-fold in NE and 4.1-fold in EX, with a significant difference 
between conditions. Starvation resulted in marked decreases in basal plasma glucose and 
insulin, without differences between groups Muscle glycogen was reduced in both conditions 




























Figure 14. Study III. Metabolic responses to starvation and exercise. NE, without exercise; 
EX, with exercise (n=9) 3 h prior to intravenous glucose tolerance test (IVGTT); FA, fatty 
acids. Muscles and blood samples were taken after an overnight fast prior to IVGTT (basal) 
and after 75 h of starvation. Values are reported as means ± SE. *P<0.05 and **P<0.001 vs. 
prestarvation; †P<0.05 and ††P<0.001 vs. NE. 
 
4.5 INSULIN SENSITIVITY 
In Study III, during the IVGTT plasma glucose was increased between 30 and 90 min in both 
groups after starvation. However, the increase was significantly higher in NE (Figure 15a and 
b). From the IVGTT, Kg decreased by 65% in NE and 37% in EX, and AUCglucose increased 
by 250 and 181% in NE and EX, respectively. Although both parameters demonstrate 
reduced glucose tolerance in both groups, they show a higher glucose tolerance in EX. Whole 
body insulin sensitivity (SIgalvin) was reduced in NE (to 59%) after starvation, in EX it was 
unchanged and therefore significantly higher. Acute insulin response and AUCinsulin 0–40 min 
decreased by 30–35% in both conditions, indicating reduced insulin secretion following 
starvation (Table 4). Phosphorylated GS Ser
641/645
 and AS160 Thr
642
 were increased by 20% 
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Figure 15. Study III. Plasma glucose and insulin concentrations during IVGTT. Tests were 
performed before and after 75-h starvation with (EX) or without exercise (NE) (n = 9). (A) 
plasma glucose, (B) plasma insulin; For clarity only, mean values are shown. *P<0.05, post 
exercise (post) vs. pre exercise (pre); †P<0.05, EX post vs. NE post. 
 
 NE EX 
















) 1.0±0.1 0.4±0.1** 0.9±0.1 0.6±0.1*† 
AUCglucose (mmol min l
-1
) 193±15 483±23** 234±19 423±26**† 
AUCinsulin 0–40 min (mU min l
-1
) 723±142 496±105** 759±139 502±101** 
Table 4. Study III. Metabolic responses to IVGTT. Kg, rate of glucose disappearance; 
AUCglucose, area under plasma glucose curve above basal; SIgalvin, Kg (AUCinsulin 0–40 min)
-1
; 1. 
Subjects (n=9) participated in 2 experimental sessions with 75 h of starvation. Values are 
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Figure 16. Study III. Effects of starvation and exercise on regulatory proteins. Muscle 
biopsies were obtained before and after 75-h starvation with (EX) or without exercise (NE) (n 
= 8). Biopsies were taken prior to IVGTT. (A) Akt substrate of 160 kDa (AS160) Thr
64
, (B) 
glycogen synthase (GS) Ser
641/645
. Values are reported as means ± SE. *P< 0.05 and 
**P<0.001 vs. pre; †P<0.05 and ††P<0.001 vs. NE post. 
 
In Study IV, OGTT showed that glucose tolerance was improved after training in RET both 
when measured as AUCglucose (-21%) and plasma glucose 2 h post glucose intake (Glu120 min -
14%) (Figure 17a and b). Applying cut off levels recommended by WHO (Glu120 min >7.8 
mmol l
-1
) (150), three individuals in the RET group were classified as having impaired 
glucose tolerance at baseline. However, following training plasma glucose was normalized in 
these three subjects. When the three subjects with impaired glucose tolerance were excluded, 
the improvements in AUCglucose and Glu120 min were no longer significant. In the CON group 
one subject developed impaired glucose tolerance over the intervention period, but mean 
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Figure 17. Study IV. Response to OGTT in plasma glucose for (A) RET, resistance exercise 
training (n=12) and (B) CON, control (n=9); RET pre training values include 3 subjects with 
impaired glucose tolerance. Values are presented as means ± SE. *p<0.05 vs pre. 
 
4.6 MITOCHONDRIAL RESPIRATION AND FA METABOLISM 
In study I, phosphorylated acetyl-CoA carboxylase (ACC) Ser
79
 did not change (Figure 18a). 
In study III, exercise during starvation lead to a significantly increase in phosphorylated ACC 
Ser
79 
(+24 %) (Figure 18c). 
 
 
Figure 18. Study I and III. The effect of the intervention on (A) p-ACC S
79
 protein levels in 
study III and (B) p-ACC S
79
 protein levels in Study I. Values are presented as means ± SEM. 
*p<0.05 vs pre; †p<0.05 vs pre.   
 
In Study III, ADP-stimulated mitochondrial respiration (state 3) with complex I substrate 
(malate + glutamate) decreased after starvation in both NE and EX (Figure 19a). When 
malate and glutamate were used with FA-derived complex I + II substrate (octanoyl-




























































































































compared to pre starvation and NE. The elevated respiration in EX remained when the 
electron flux was uncoupled from ATP production (FCCP) and after inhibition of complex I 
with rotenone (Figure 19b). In study I, mitochondrial respiration, measured after sequential 
additions of ADP and substrates, was similar before and after exercise without difference 
between LG and NG (data not shown). 
 
Figure 19. Study III. Mitochondrial respiration. Muscle biopsies were obtained before (pre) 
and after (post) 75-h starvation with (EX) or without exercise (NE) (n = 9). Biopsies were 
taken prior to IVGTT. (A) ADP-stimulated respiration (state 3) with malate and octanoyl-
carnitine (MO), MO+glutamate (MOG), MOG+succinate (MOGS), MOGS+FCCP 
(+FCCP), and MOGS+FCCP+rotenone (+Rot) (protocol 1). (B) ADP-stimulated 
respiration (state 3) with malate+glutamate (MG; protocol 2). Values are reported as means 
± SE. *P<0.05 vs. pre; †P<0.05 vs. NE post; _*_ P<0.05, main effect of starvation vs pre. 
 
4.7 OXIDATIVE STRESS 
In Study III, mitochondrial H2O2 production was reduced after starvation in both conditions 
with no difference between conditions (Figure 20a). In Study I, mitochondrial H2O2 
production showed a strong trend (p=0.053) towards reduction 3 h after test exercise (Figure 
20b). Glutathione status after test exercise also indicated reduced oxidative stress in that 
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GSSG/GSH ratio tended to be lower (p=0.076) (Fig. 20c). The exercise-induced trends of 
changes in mitochondrial H2O2 production and glutathione status were not different between 
LG and NG. Muscle content of MDA, a marker of lipid peroxidation, was not changed by 
exercise in neither condition (data not shown). 
 
Figure 20. Study I and III. Mitochondrial emission of H2O2 and GSSG/GSH. NE, no 
exercise; LG, low glycogen; NG, normal glycogen; EX, exercise; (A) mitochondrial H2O2 
emission with octanoyl-carnitine+glutamate+succinate in study III (n = 9); (B) 
mitochondrial H2O2 emission with octanoyl-carnitine+pyruvate+succinate in study I (n = 8). 
(C) GSSG/GSH ratio in study I (n =5). Values are reported as means ± SE. _*_ P<0.05, 
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5 METHODOLOGICAL CONSIDERATIONS 
5.1 IVGTT/OGTT 
In Study III, glucose tolerance was measured with an IVGTT. Insulin sensitivity was then 
calculated using a method by Galvin, which correlates well with that obtained during 
euglycaemic hyperinsulinaemic clamp (54, 141). In Study IV, OGTT was used and insulin 
sensitivity was calculated using the Matsuda method, which also has been validated with the 
clamp method (2). However, there are certain limitations with both methods, such as unstable 
insulin levels, the inability to distinguish between insulin-dependent and insulin-independent 
glucose removal and between hepatic and peripheral insulin sensitivity (99). However, in 
contrast to the clamp, both OGTT and IVGTT provide information about the release of 
insulin in response to hyperglycaemia. 
The difference between OGTT and IVGTT is whether the glucose bolus is ingested or 
infused. This results in different advantages with both methods. Ingesting the glucose is 
simple and mimics better the dynamics of physiological conditions, i.e. eating a meal. 
However, infusing the glucose gives more reliable plasma levels by bypassing gastro 
intestinal metabolism and absorption. 
5.2 MITOCHONDRIAL RESPIRATION 
The temperature during measurement in Study I was 25 °C and in Study III 37 °C. The 
reason for the lower temperature in Study I was concern about the stability of the 
mitochondria. However, following tests, long-term (five-hour) measurements at 37 °C only 
reduced respiration by ~20% and therefore the more physiological temperature was selected. 
5.3 MARKERS FOR MITOCHONDRIAL CONTENT 
Different markers for mitochondrial content were used in Study II and Study IV. In Study II 
CS activity was used and in Study IV the protein content of CS and OXPHOS complexes II, 
III and IV. Larsen and colleagues (89) correlated several markers for mitochondrial content 
with the golden standard, the transmission electron microscope. Of the methods we used, they 
found the strongest correlation for CS activity (r=0.84, p<0.001), then Complex II protein 
content (r=0.73, p=0.005), Complex III protein content (r=0.61, 0.03) and Complex IV 
protein content (r=0.55, p=0.05). They did not measure CS protein content. It is clear that in 
both Study II and Study IV, reliable markers for mitochondrial content were used. 
5.4 WESTERN BLOT 
Western blot is a method used all through the studies and it is therefore of importance. It is a 
well-known method that has been established for a long time at our lab. However, in the last 
study the method was modified. In Studies I–III the muscle homogenate was centrifuged to 
discharge myofibrillar debris. In Study IV, this step was disregarded to eliminate the possible 
loss of relevant proteins 
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6 DISCUSSION 
6.1 TRAIN LOW 
Study I investigates the effect of exercise with low or normal levels of muscle glycogen on 
mitochondrial biogenesis. The subjects performed one depletion exercise, followed 14 hours 
later by a test exercise. In one condition they received carbohydrates following the depletion 
exercise session and in the other they did not. In the condition when they did not consume 
carbohydrates, glycogen levels were significantly lower compared to the other condition. The 
major finding in Study I was a profound increase in mRNA expression of PGC-1α following 
exercise with low glycogen levels. This may, over a training period, result in increased 
mitochondrial density and thereby improved performance. 
In a more recent study Bartlett and colleagues confirm several of our findings (14). In their 
study, the timing of the biopsies was similar to ours, but the set up differed somewhat. A 
depletion exercise was only performed in the low glycogen group, and between exercise 
sessions the group fasted. They found that PGC-1α mRNA was up-regulated three hours 
post-exercise, which is the same as our study. In contrast to our study, PGC-1α was up-
regulated prior to test exercise, 10–12 hours post-depletion exercise. In our study, pre-test 
biopsies were taken at least two hours later, and it is possible PGC-1α returned to basal levels 
during this time. However, a longer expression of PGC-1α in Bartlett and colleagues is 
reasonable considering the lower training level of the subjects and the different diet regime. 
When glycogen levels are manipulated by an exercise and nutritional intervention, other 
metabolic changes will occur as a consequence. One difference between the groups was the 
calorie intake which was about three times larger in NG compared to LG. Calorie restriction 
has been shown to up-regulate PGC-1α and increase mitochondrial biogenesis (36, 50). 
However, these studies are performed over a longer period of time (six months), and over a 
period of 24-hour fasting it does not affect PGC-1α mRNA or protein levels (140). Insulin is 
a potent signal inducer and PGC-1α seems to play a role in insulin sensitivity (90). However, 
previous research shows that insulin does not suppress expression of PGC-1α two to five 
hours post-exercise (38, 110). Another possibility is the influence of elevated plasma FA. 
Prolonged (48-hour) lipid infusion suppresses PGC-1α mRNA (114). In contrast, fasting for 
24 or 48 hours with increased circulating FA did not alter PGC-1α mRNA and protein 
expression (140). Altogether, it seems that the glycogen content during exercise, rather than 
calorie intake, plasma insulin or FA levels, is responsible for the pronounced increase in 
PGC-1α. 
6.2 CONCURRENT EXERCISE 
Study II investigates the effect of adding resistance training to endurance training on markers 
of mitochondrial content. The study was performed in trained subjects with cycling 
experience, and the aim was to maintain their regular exercise routines during the 
intervention in both groups, and then add resistance training to one of them. The study was 
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designed so two exercise sessions per week were exchanged for supervised training sessions 
at the lab; for the remaining week the subjects trained as usual. At these sessions both groups 
performed an endurance exercise session and then the ES group performed a session of 
strength training using the leg press machine. 
Although the ES group increased strength (one RM during leg press), peak power output 
during 30 seconds of Wingate cycling and short-term endurance (TTE-VO2max), they did not 
increase mitochondrial density (CS activity) or long-term endurance performance (TT40 and 
LT4). In contrast, the E group improved mean power during TT40 (+4%) and LT4 (+3%). 
In study II we used a similar load (6 x 65–75%, one RM) during the resistance training, as in 
our previous study (145) and the one by Sale and colleagues (123). Training order, and 
strength prior to endurance, were also the same. Even so, our results correspond better with 
the study by Nelson et al (100) in which the subjects trained with a heavier load (3 x 6 RM) 
and performed the resistance exercise prior to the endurance exercise. In the study by Nelson 
et al the endurance group improved and the concurrent group did not. In addition, there was a 
significant difference between groups in CS activity and VO2max. The explanation for the 
great responses following training is probably the low training levels of their subjects. 
However, the study included very few subjects (four in the endurance group and five in the 
concurrent group) and should therefore be interpreted with caution (100). 
The lack of improvements in endurance performance and markers of mitochondrial 
biogenesis in Study II is probably, at least partly, due to the training level of the subjects. This 
is the first study to investigate the effect of concurrent exercise on markers for mitochondrial 
biogenesis in trained subjects. When investigated separately, resistance training seems to 
increase mitochondrial biogenesis in the untrained (124, 151), while in the trained, this is 
usually not the case (59, 151). This notion is also supported by Study IV, in which resistance 
training in the untrained elderly resulted in a profound increase in mitochondrial proteins. It is 
therefore reasonable that the outcome also depends on the training level of the subjects, when 
resistance training is combined with endurance training. 
In contrast to our theory, long-term endurance performance did not increase after concurrent 
exercise training. Previous research in this area is contradictory, with studies finding an 
improved performance using heavy strength training with high loads (85–95%, 1 RM) and 
long durations (>8 weeks) (1, 119). It is possible that the strength training in our study was 
not heavy enough (65–75%, 1RM) or did not proceed long enough (eight weeks) to improve 
performance. In addition, most previous research used low or moderately trained subjects (19, 
22, 64), while we used trained subjects. Similar to mitochondrial biogenesis, the effect on 
performance is most likely less profound in the trained. In another study that used trained 
subjects, concurrent exercise did not improve long term endurance performance (16). 
In conclusion, we could not find any additional benefits of adding resistance to endurance 
training on mitochondrial density or endurance performance. For any potential benefit in 
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trained individuals, a longer period of training or alternative resistance training strategy is 
probably needed. 
6.3 STRENGTH TRAINING IN THE ELDERLY 
In Study IV elderly subjects (>65 years) performed heavy strength training (80%, 1RM) for 
eight weeks. The study is unique since it demonstrates a broad span of simultaneously 
occurring positive effects from resistance exercise training. The main findings of the study 
were that short-term resistance training in the elderly, in addition to improving strength, also 
improved glucose tolerance and muscle oxidative capacity. 
Resistance training resulted in hypertrophy measured as increases in FFM, thigh 
circumference and thigh cross-sectional area. However, fiber CSA did not increase. Knee 
extensor strength for static, eccentric and concentric contraction increased by 8–12%. The 
increased RTD during the initial phase of contraction (0-30 ms), but not between 0-200 ms, is 
in line with previous findings (23). Increased muscle mass, strength and power are all well-
known effects of resistance exercise in the elderly (72) and have important implications for 
health by prevention of fall injuries and increasing quality of daily life. The underlying 
molecular signaling pathways for muscle atrophy in the elderly are not fully understood. An 
interesting novel finding in the present study is the increased levels of signaling proteins 
involved in muscle protein synthesis (mTOR and Akt) in RET. The elderly have a reduced 
level of mTOR protein in muscle (42), which may restrict protein synthesis. Therefore, the 
observed increase in mTOR in RET may counteract any possible anabolic resistance and 
contribute to hypertrophy. 
The most recognized test for the assessment of VO2max and aerobic capacity is incremental 
exercise to fatigue, but the frailty of the subjects in this study prevented this test. Instead, 
changes in HR and RER during submaximal cycling were used as an indication of changes in 
aerobic capacity. The tendencies of decreased HR in RET and increased HR in CON suggest 
that resistance training improved VO2max. Furthermore, the reduced RER at high intensity in 
RET, which indicate reduced lactic acid formation, support the view of improved aerobic 
capacity. The majority of previous studies (26, 52, 152), but not all (30), have shown that 
VO2max increases after RET in aged subjects. 
In addition to the improved whole body aerobic capacity, markers for muscular oxidative 
capacity improved. Fiber type composition shifted from fast twitch glycolytic Type IIx fibers 
towards more oxidative Type IIa fibers, and several mitochondrial proteins (OXPHOS 
complex II, IV and CS) increased markedly. Mitochondrial density and maximal respiration 
are reduced in the elderly, probably to a large part caused by physical inactivity (109). 
Endurance exercise training in the elderly is known to increase markers of muscle oxidative 
capacity i.e. OXPHOS protein content (56) and CS activity (87). However, the effect of RET 
is more contradictory. Studies show increased (52) or unchanged (47) CS activity. 
Mitochondrial volume measured with electron microscopy was increased in one study (80) 
and unchanged in another (139). Parise et al found that OXPHOS complex IV activity 
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increased with RET (105), and this is in similarity with the increased protein content in our 
study. Consistent with previous findings in young subjects (84), there were no changes in 
PGC-1α protein levels following RET. Although protein levels did not increase, we cannot 
conclude anything about the involvement of PGC-1α activity in mediating the mitochondrial 
biogenesis. The discrepancies between studies may depend on several factors like exercise set 
up, duration or analytical procedures. 
The robust increases in mitochondrial proteins in Study IV after only eight weeks of training 
clearly demonstrates that resistance training in the elderly is an efficient strategy to improve 
muscle oxidative capacity. In addition, strength, power, HR during submaximal cycling and 
glucose tolerance improved. In contrast, the training status in the control group was impaired 
during the intervention period (reduced concentric torque, increased HR and RER during 
submaximal exercise). This is likely related to that the intervention period which occurred 
during autumn (September–November), which is a period when the degree of physical 
activity, especially in the elderly, is reduced. 
6.4 INSULIN SENSITIVITY 
In Study III, the effect of endurance exercise on starvation-induced insulin resistance was 
investigated. The main finding was that the impaired whole body insulin sensitivity and 
glucose tolerance after starvation were reversed or attenuated by exercise. Exercise was 
accompanied by reduced glycogen stores, increased lipid oxidation capacity, and alterations 
in signaling proteins involved in glucose and FA metabolism. 
Consistent with previous studies, starvation resulted in hypoglycemia and reductions in 
plasma insulin, insulin sensitivity (34) and acute insulin response (49). In addition, plasma 
levels of FA and ketone bodies (i.e. BOH) increased markedly after starvation and 
demonstrate a metabolic state with increased lipid load. As mentioned previously, the surplus 
of lipids is associated with reduced insulin sensitivity and the mechanism has been attributed 
to an accumulation of toxic lipid intermediates and increased ROS formation (143). BOH, on 
the other hand, induces insulin resistance through an ROS-independent mechanism (156). 
Glycogen levels are closely linked to insulin sensitivity (115). Even though muscle glycogen 
decreased significantly during starvation, insulin sensitivity was reduced. It appears that the 
level of glycogen depletion (reduced by 27%) was not sufficient to reverse insulin resistance. 
Previous research also shows slightly reduced glycogen levels appearing simultaneously with 
starvation-induced insulin resistance (34). Following exercise, the reduction in glycogen 
levels was more pronounced (reduced by 70%). Since post-exercise insulin sensitivity 
correlates with the amount of glycogen broken down during exercise (115), it is likely that 
the greater reduction is what caused the insulin resistance to reverse. Although the 
mechanism for how glycogen levels affect insulin sensitivity is unclear, it involves an 
increase in levels of membrane bound GLUT4 (115). GLUT4 is a glucose transporter and its 
presence in the membrane is a limiting factor for transmembrane glucose transport (Figure 
21). The time period between exercise and biopsy was too short (three hours) for protein 
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translation to occur, and even so, levels of total GLUT4 were unchanged. Therefore the 
explanation is likely increased translocation of GLUT4 to the cell membrane. GLUT4 
translocation to the surface membrane is stimulated synergistically by insulin and exercise, 
and the signaling cascades converge at Rab GTPase activating proteins, which include AS160 
and TBC1D1 (33). 
 
 
Figure 21. Insulin and exercise stimulated GLUT4 membrane translocation and glucose 
uptake. IR, insulin receptor; GLUT4, glucose transporter 4; GS, glycogen synthase; AS160, 
Akt substrate of 160 kDa. 
 
Consistent with previous studies (131) starvation did not affect the basal levels of the insulin 
signaling molecules p-Akt and p-AS160 (using p-AS160-thr
642
). However, previous research 
shows that starvation significantly decreases insulin-stimulated phosphorylation of Akt and 
AS160-thr
642
 (131). This suggests that starvation induces insulin resistance in human skeletal 
muscle by interfering with insulin signaling. In Study III AS160 phosphorylation was 
increased markedly (+138%) three hours after exercise, suggesting that the exercise-mediated 
enhancement of glucose tolerance and insulin sensitivity after starvation were related to 
enhanced glucose transport. It is likely that the increased AS160 phosphorylation was 
mediated by AMPK (even though p-AMPK was unaltered three hours post-exercise), as 
judged by elevated levels of the AMPK target p-ACC. 
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Impaired glycogen storage is considered to have a major role in insulin resistance (17, 129). 
Glycogen synthase (GS) is the rate-limiting enzyme for glycogen synthesis, and the activity is 
controlled by phosphorylation (inactivation) and dephosphorylation (activation), with insulin 
and low glycogen levels being factors that promote activation (117). Consistent with previous 
findings (34), Study III shows that starvation caused a significant increase in GS 
phosphorylation (i.e. inactivation). However, it was previously demonstrated that activation 
of GS during euglycemic hyperinsulinemia was not impaired after a three-day fast (34), 
indicating that starvation-induced insulin resistance is not caused by reduced GS activation. 
Prolonged exercise resulted in a marked dephosphorylation (i.e. activation) of GS and this has 
previously been shown by measurements of GS fractional activity as well (77). Thus it is 
possible that exercise-mediated activation of GS contributed to improved insulin action 
following starvation. 
In Study IV, the long-term effect of resistance training on glucose tolerance was investigated 
in the elderly. Despite the short period of intervention (eight weeks) we observed an 
improved glucose tolerance in RET as shown by the reduction in AUCglucose and Glu120 min. 
This contention is supported by previous findings where glucose tolerance is improved by 
RET in the elderly (>65 years) with impaired glucose tolerance (122) or T2D (73), whereas 
the effect of long-term (four to six months) RET in healthy aged subjects show either an 
improvement (158) or no improvement of insulin sensitivity (44). 
The increase in muscle mass after RET will increase the volume for glucose disposal and thus 
contribute to the increased glucose tolerance. In addition, resistance training increases 
insulin-mediated glucose uptake per unit of skeletal muscle, which indicates qualitative 
changes (5). An increased level of mitochondrial proteins is a qualitative improvement that 
may improve insulin sensitivity. As mentioned previously, increased mitochondrial density 
improves fat oxidation (69). This increases the ability of the mitochondria to cope with a high 
lipid load and may thereby improve insulin sensitivity. 
In summary, starvation-induced insulin resistance may be caused by increased levels of lipids 
or BOH. During starvation, the mitochondrial capacity to produce ROS is reduced. When 
exercise is performed during starvation, insulin resistance is attenuated. The effect is 
associated with reduced glycogen levels and activation of GS and AS160, which are possible 
mediators of the effect. Although resistance training in the elderly improves glucose 
tolerance, the effect seems more pronounced in individuals with impaired glucose tolerance. 
The effect may, at least partly, be explained by increased amounts of mitochondrial proteins. 
6.5 MITOCHONDRIAL RESPIRATION AND FA METABOLISM 
In Study III, phosphorylation of ACC and mitochondrial respiration with Complex I+II 
substrates was increased following exercise during starvation. Lipid oxidation is in part 
controlled by mitochondrial uptake of long-chained FA via (carnitine palmitoyltransferase I) 
CPT-1. Malonyl-CoA inhibits CPT-1 and the formation of malonyl-CoA is controlled by the 
activity of ACC. Phosphorylation inhibits ACC, which decreases the formation of malonyl-
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CoA and thereby stimulates mitochondrial FA uptake (153). However, the increase in p-ACC 
cannot explain the increased mitochondrial respiration with Complex I+II substrates in vitro. 
The substrate used, octanoyl-carnitine, is a medium-chain FA and therefore not transported 
by CPT-1 (28). Even so, increased phosphorylation of ACC and increased mitochondrial 
respiration with complex I+II substrates suggest that there is an increased capacity for the 
mitochondria to transport and oxidize lipids after exercise. 
Study III confirms previous research that shows an increase in p-ACC following exercise 
(146, 154). However, within three hours the amount of p-ACC has returned to basal levels in 
both trained and untrained subjects (146, 154). It seems that the metabolic state in Study III, 
i.e. increased plasma FA and reduced glucose availability, elongated the ACC 
phosphorylation. In contrast, p-ACC did not change despite a similar metabolic state in Study 
I. This is most likely due to the training level of the subjects, with a more prolonged response 
in the untrained subjects in Study III. Phosphorylation of the upstream regulator of ACC, 
AMPK, was not affected in either study. As with p-ACC, p-AMPK levels return to basal 
within three hours, and it is likely we missed that window due to the timing of the biopsies 
(146, 154). 
In Study III starvation resulted in reduced mitochondrial ADP stimulated respiration with 
Complex I substrates. In a similar study, 60 hours of fasting resulted in decreased respiration 
with Complex I+II substrates as well as during maximal uncoupled conditions (67). A novel 
interesting finding was the increase in mitochondrial Complex I+II substrate oxidation when 
starvation was followed by exercise. It has previously been shown that both high (three 
intervals at 130% VO2max to exhaustion) and moderate (70% VO2max) intensity can 
increase State 3 respiration in permeabilized fibers for at least three hours (130, 138). When 
exercise is performed during starvation there is an increased reliance on fat oxidation (82); 
this study shows that the effect is sustained on a mitochondrial level for at least three hours. 
Since respiration with Complex I substrates was unaffected by exercise in Study III, the 
results demonstrate a substrate-specific mitochondrial adaption. Although exercise can 
increase Complex I respiration (130, 138), Complex I+II respiration is more pronounced 
following exercise in states of high lipid availability, e.g. high-fat diet or ultra-endurance 
exercise (46, 130). Considering that both mitochondrial respiration and p-ACC increased in 
Study III, it shows that exercise-induced mitochondrial FA metabolism was creased in Study 
III. 
In contrast to Study III, exercise did not increase mitochondrial respiration capacity in Study 
I, even though the subjects had low plasma glucose, glycogen and high plasma FA. Neither 
was p-ACC increased. They performed a similar exercise session at moderate intensity in 
repeated 10 minute intervals. The reason for this is likely the training level of the subjects. In 
previous research, as in Study III, the subjects were recreationally active (130, 138) while in 




The mitochondrial ROS production capacity was reduced in Study III, and showed a trend 
towards reduction in Study I. Although acute exercise may alter mitochondrial respiration 
(130, 138), ROS production capacity is unaffected three hours following moderate intensity 
exercise under the current conditions. In Study I, there was a trend towards reduced 
GSSG/GSH, and MDA, a marker for lipid peroxidation, was unaffected. The exercise was 
performed at an intensity of 72.5–60% of VO2max, and previous research shows that 
oxidative stress predominantly occurs at higher intensities (48, 92). Even though several of 
the subjects in both studies felt exhausted and could not finish the exercise session at the 
initial intensity, it seems that the intensity was too low to induce oxidative stress. 
Although the exercise intensity and duration can explain the lack of increases in ROS 
production capacity and GSSG/GSH, it does not explain why they decreased. Previous 
research shows that a state of energy or nutrient deficiency reduces ROS production in mice 
(127). In both Study I and Study III, plasma glucose and muscle glycogen were reduced and 
FFA increased. Plasma FFA increased in all groups except NG in Study I. Since ROS 
production also was reduced in that group, FFA is probably not the cause. In addition, high 
levels of FA are associated with increased ROS production (7). 
Statistical analyzes were performed with two-way repeated measures ANNOVA, and no 
differences in ROS production was found between groups. However, when the ROS 
production in Study I was analyzed with a T-test for each group separately, it was reduced in 
LG (p=0.019) but not in NG. This can be interpreted as a more pronounced reduction in ROS 
production in LG. LG differs from NG and Study III by having exogenous glucose provided, 
which increased glycogen levels and nearly returned plasma glucose to basal levels. High 
glucose availability increases ROS production in muscle cells (97) and it is possible that ROS 
production is attenuated by low glucose availability. This, however, needs further research. 
In summary, we could not find any signs of oxidative stress mediating the pronounced 
increase in PGC-1α mRNA in Study I. It is likely that during moderate-intensity exercise 
with low glycogen levels, PGC-1α mRNA is predominantly regulated by other signals. In 
addition, moderate-intensity exercise, even when performed to near exhaustion in a state of 
reduced glycogen stores, is not sufficient to increase mitochondrial ROS production capacity. 
However, starvation and long-term (>17 hours) reduction in glycogen stores is associated 
with reduced mitochondrial ROS production capacity. 
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7 CONCLUSION 
 
 Training with low glycogen levels is an efficient strategy to increase mRNA levels 
of PGC-1α, a marker for mitochondrial biogenesis. The effect is likely caused by 
reduced glycogen levels rather than plasma insulin, plasma FA or oxidative stress. 
This shows that training with low glycogen stores may increase mitochondrial 
content and thereby performance. 
 
 Adding resistance training to endurance training did not improve mitochondrial 
density or endurance performance in trained individuals. 
 
 Resistance training over a short period of time is an efficient strategy to improve 
strength, aerobic capacity (HR during submaximal cycling) and glucose tolerance. 
The improvements may, at least partly, be explained by an increased amount of 
mitochondrial and hypertrophy signaling proteins. 
 
 Starvation induces insulin resistance, and when exercise is performed, the insulin 
resistance is reversed. This is likely explained by reduced glycogen stores, increased 
p-AS160 and reduced p-GS. 
 
 Starvation reduces mitochondrial respiration with Complex I substrates and ROS 
production capacity. When exercise is performed during starvation, p-ACC and 
mitochondrial respiration capacity with FA substrates are increased. 
 
 Moderate-intensity exercise, even when performed to near exhaustion in a state of 
reduced glycogen levels, seems not to affect mitochondrial ROS production 
capacity or oxidative stress. 
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